Intrommune CSO Erick Berglund will present the talk "Intrommune Therapeutics: Targeting Food Allergies with Oral Mucosal Immunotherapy" at the 3rd Annual SMi Conference on Allergies.
- Oral Mucosal Immunotherapy (OMIT) as a new modality for delivering allergen-specific desentitization therapy
- INT-301: lead OMIT candidate for treating peanut allergy
- Proof of concept data for INT-30
Event: 3rd Annual SMi Conference on Allergies
Event page: http://www.smi-online.co.uk/pharmaceuticals/uk/allergies
Location: Holiday Inn Kensington Forum, London, UK